Prognostic markers in bladder cancer: a contemporary review of the literature

JP Stein, GD Grossfeld, DA Ginsberg, D Esrig… - The Journal of …, 1998 - auajournals.org
Purpose : We provide a contemporary review of bladder tumor markers and summarize their
role as prognostic indicators. Materials and Methods : A comprehensive review of the …

[HTML][HTML] Accumulation of nuclear p53 and tumor progression in bladder cancer

D Esrig, D Elmajian, S Groshen… - … England Journal of …, 1994 - Mass Medical Soc
Background We have previously demonstrated a strong association between nuclear
accumulation of p53 protein, as determined by immunohistochemical analysis, and mutations in …

Two molecular pathways to transitional cell carcinoma of the bladder

…, PF Ohneseit, M Gonzalez-Zulueta, D Esrig… - Cancer research, 1994 - AACR
Noninvasive transitional cell carcinomas of the bladder can have two distinct morphologies
suggesting they contain different genetic alterations. Papillary transitional cell carcinomas (T …

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

D Esrig, CH Spruck 3rd, PW Nichols… - The American journal …, 1993 - ncbi.nlm.nih.gov
… The tumors in A and B did not demonstrate mtutations in thep53 gene hy wSSCP whereas
mutationzs were fotnnd in the tumors shoun in C and D (tuimors 24 and 20. respectively Table …

Management of the patient with bladder cancer: urethral recurrence

JA Freeman, D Esrig, JP Stein, DG Skinner - Urologic Clinics of North …, 1994 - Elsevier
Urethral recurrence develops in roughly 10% of patients following cystectomy for bladder
cancer and appears to be another manifestation of the multicentric nature of TCC. By far the …

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

…, JP Stein, BH Bochner, D Esrig… - Journal of the …, 1997 - academic.oup.com
Background: Thrombospondin-1 (TSP) is a 430-kd glycoprotein that is an important
component of the extracellular matrix and is known to be a potent inhibitor of angiogenesis (ie, …

Effect of p21WAF1/CIP1 Expression on Tumor Progression in Bladder Cancer

…, GD Grossfeld, SJ Chatterjee, D Esrig… - JNCI: Journal of the …, 1998 - academic.oup.com
Background: Altered expression of p53 protein is an important predictor of progression in
bladder cancer. The action of p53 on cell cycle regulation is mediated, in part, through …

[HTML][HTML] Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status

…, JP Stein, SR Shi, D Raghavan, D Esrig… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
… (C) Estimated cumulative incidence curves for time to recurrence and (D) Kaplan-Meier
curves for overall survival among patients with p53-altered tumors in patients randomly assigned …

Urethral recurrence in patients with orthotopic ileal neobladders

JA Freeman, TA Tarter, D Esrig, JP Stein… - The Journal of …, 1996 - auajournals.org
Purpose : We identified the risk of urethral recurrence following cystectomy for transitional cell
bladder carcinoma, stratified by pathological characteristics of the bladder tumor and type …

The Kock ileal neobladder: updated experience in 295 male patients

DA Elmajian, JP Stein, D Esrig, JA Freeman… - The Journal of …, 1996 - auajournals.org
Purpose : Since 1986 orthotopic lower urinary tract reconstruction using the Kock ileal
neobladder has been our diversion of choice in patients undergoing cystectomy. We report on the …